×
About 345 results

ALLMedicine™ Parathyroid Hormone-related Peptide Center

Research & Reviews  171 results

Novel bone-targeted parathyroid hormone-related peptide antagonists inhibit breast canc...
https://doi.org/10.1097/CAD.0000000000001051
Anti-cancer Drugs; Ponnapakkam T, Anbalagan M et. al.

Feb 17th, 2021 - Patients with advanced breast cancer often develop bone metastases. Treatment is limited to palliative care. Parathyroid hormone (PTH)/parathyroid hormone-related peptide (PTHrP) antagonists for bone metastases failed clinically due to short half-...

Severe hypercalcemia caused by parathyroid hormone in a rectal cancer metastasis: a cas...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792014
BMC Endocrine Disorders; Brun VH, Knutsen E et. al.

Jan 8th, 2021 - Hypercalcemia of malignancy is relatively common in several cancers. However, in colorectal cancer, paraneoplastic phenomena that cause hypercalcemia is uncommon. In the few cases that are reported, secretion of parathyroid hormone-related peptide...

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500469
The Journal of Clinical Endocrinology and Metabolism; Cosman F, Peterson LR et. al.

Jul 13th, 2020 - Abaloparatide is a US Food and Drug Administration-approved parathyroid hormone-related peptide analog for treatment of osteoporosis in postmenopausal women at high risk of fracture. We assessed the cardiovascular safety profile of abaloparatide. ...

Early Addition of Parathyroid Hormone-Related Peptide Regulates the Hypertrophic Differ...
https://doi.org/10.1177/1947603519894727
Cartilage Rajagopal K, Ramesh S et. al.

Jan 1st, 2020 - Chondrogenic differentiation of mesenchymal stem cells (MSCs) into hyaline cartilage is complicated by terminal hypertrophic differentiation. In growth plate, parathyroid hormone-related peptide (1-34) (PTHrP) plays a crucial role in maintaining c...

A three-dimensional analysis of primary failure of eruption in humans and mice.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608053
Oral Diseases; Tokavanich N, Gupta A et. al.

Dec 5th, 2019 - Primary failure of eruption (PFE) is a genetic disorder exhibiting the cessation of tooth eruption. Loss-of-function mutations in parathyroid hormone (PTH)/parathyroid hormone-related peptide (PTHrP) receptor (PTH/PTHrP receptor, PPR) were reporte...

see more →

Clinicaltrials.gov  173 results

Novel bone-targeted parathyroid hormone-related peptide antagonists inhibit breast canc...
https://doi.org/10.1097/CAD.0000000000001051
Anti-cancer Drugs; Ponnapakkam T, Anbalagan M et. al.

Feb 17th, 2021 - Patients with advanced breast cancer often develop bone metastases. Treatment is limited to palliative care. Parathyroid hormone (PTH)/parathyroid hormone-related peptide (PTHrP) antagonists for bone metastases failed clinically due to short half-...

Severe hypercalcemia caused by parathyroid hormone in a rectal cancer metastasis: a cas...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7792014
BMC Endocrine Disorders; Brun VH, Knutsen E et. al.

Jan 8th, 2021 - Hypercalcemia of malignancy is relatively common in several cancers. However, in colorectal cancer, paraneoplastic phenomena that cause hypercalcemia is uncommon. In the few cases that are reported, secretion of parathyroid hormone-related peptide...

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis: Analy...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500469
The Journal of Clinical Endocrinology and Metabolism; Cosman F, Peterson LR et. al.

Jul 13th, 2020 - Abaloparatide is a US Food and Drug Administration-approved parathyroid hormone-related peptide analog for treatment of osteoporosis in postmenopausal women at high risk of fracture. We assessed the cardiovascular safety profile of abaloparatide. ...

Early Addition of Parathyroid Hormone-Related Peptide Regulates the Hypertrophic Differ...
https://doi.org/10.1177/1947603519894727
Cartilage Rajagopal K, Ramesh S et. al.

Jan 1st, 2020 - Chondrogenic differentiation of mesenchymal stem cells (MSCs) into hyaline cartilage is complicated by terminal hypertrophic differentiation. In growth plate, parathyroid hormone-related peptide (1-34) (PTHrP) plays a crucial role in maintaining c...

A three-dimensional analysis of primary failure of eruption in humans and mice.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608053
Oral Diseases; Tokavanich N, Gupta A et. al.

Dec 5th, 2019 - Primary failure of eruption (PFE) is a genetic disorder exhibiting the cessation of tooth eruption. Loss-of-function mutations in parathyroid hormone (PTH)/parathyroid hormone-related peptide (PTHrP) receptor (PTH/PTHrP receptor, PPR) were reporte...

see more →

News  1 results

Cardiovascular Safety of Abaloparatide in Postmenopausal Women With Osteoporosis
https://www.medscape.com/viewarticle/938943

Abstract and Introduction Abstract Context: Abaloparatide is a US Food and Drug Administration-approved parathyroid hormone-related peptide analog for treatment of osteoporosis in postmenopausal women at high risk of fracture. Objectives: We asses...

see more →